Attitudes of African-Americans regarding prostate cancer clinical trials

Journal of Community Health

Volumn 21, Issue 2, 1996, Pages 77-87

  Robinson, Susan B ^a,b   Ashley, Mary ^a   Haynes, M Alfred ^a  

^a DREW UNIVERSITY   (United States)

^b Drew/Meharry/Morehouse Consortium C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PATIENT ATTITUDE; PROSTATE CANCER; SOCIOECONOMICS; AFRICAN AMERICAN; AGED; ATTITUDE TO HEALTH; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; HEALTH EDUCATION; INFORMATION PROCESSING; MIDDLE AGED; MOTIVATION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; UNITED STATES; URBAN POPULATION;

ADULT; AFRICAN AMERICANS; AGED; ATTITUDE TO HEALTH; CLINICAL TRIALS; EDUCATIONAL STATUS; FOCUS GROUPS; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOS ANGELES; MALE; MIDDLE AGED; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN-PATIENT RELATIONS; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 0029666361     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01682300     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures 1995. American Cancer Society, Incorporation. Publication No. 5008, 1995, pp 10-12.
2. Miller BA, Ries LAG, Hankely BF, Kosary CL, Harras A, Devesa SS, and Edward BK (Eds). SEER Cancer Statistics Review: 1973-1990, National Cancer Institute. NIH Publication No. 93-2789, 1994.
3. Kurihara M, Aoki K, and Hisamichi S (Eds). Cancer Mortality Statistics in the World 1950-1985. Nagoya, Japan; University of Nagoya Press,1984.
4. Flemming C, Wasson JH, Albersen PC, Barry MJ, and Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer: prostate Patient Outcomes Research Team. JAMA 1993;269:2650-2658.
5. Moskovitz B, Nitecki A, and Richter L. Cancer of the prostate: is there a need for aggressive treatment? Urology Int 1987;42:49-52.
6. George NR. Natural history of localized prostatic cancer managed by conservative therapy alone. Lancet 1988; 1:494-497.
7. Handley R, Carr TW, Travis D, Powell PH, and Hall RR. Deferred treatment for prostate cancer. Br J Urol 1988; 62:249-253.
8. Chodak GW, Trusted RA, Berber GS, and et al. Results of conservative management of clinically localized prostate cancer. New Eng J Med 1994; 330:242-248.
9. Elder J, Jeweet H, and Walsh P. Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 1983; 127:704-706.
10. Goodman C , Busuttil A, and Chisholm G. Age and size and grade of tumor predict prognosis in incidentally diagnosed carcinoma of the prostate. Br J Urol 1988; 62:576-580.
11. Whitmore W, Warner J, and Thompson I. Expectant management of localized prostatic cancer. Cancer 1991; 67:1091-1097.
12. Johansson JE, Adami HO, Anderson SO, and et al. High 10 year survival rate in patients with early untreated prostatic cancer. JAMA 1992; 267:2191-2196.
13. Zaluzny A, Brawley O, Garson-Angert D, and et al. Assuring access to state of the art care for US minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst 1993; 85: 1945-1950.
14. Lee JY, Marks JE and Simpson JR. Recruitment of patients to Cooperative Group Clinical Trials. Cancer Clin Trials 1980; (3) 381-384.
15. Lee JY and Breaux SR, Accrual of radiotherapy patients to clinical trials. Cancer 52:1014-1016, 1983.
16. Martin J, Henderson R, Zacharski L, and et al. Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies. Am J Clin Oncol 1984; 7:173-182.
17. Begg CV, Carborbe PP, Elson PJ, and et al. Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group. New England J Med 1983; 306:1076-1080.
18. Hunter CP, Frelick RW, Feldman AR, and et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treat Reports 1987; 71:559-563.
19. Barbie, E. The Practice of Social Research. Belmont, CA: Wadsworth, 1989, pp. 20-29.
20. Dignan M, Michielutte R, Sharp P, Bahnson J, Young L, and Beal P. The role of focus groups in health education programs for cervical cancer among minority groups. J Comm Health 1990; 15:369-375.
21. Morgan DL, and Kruger RA. When to Use Focus Groups and Why? In. Morgan DL (Ed). Successful Focus Groups: Advancing the State of the Art. Sage Publications,Newburg CA: 1993, pp 3-19.
22. Myers RE, Thomas WA, Balshiem AM, Ross EA and Chodak GW. Receptivity of African-American men to prostate cancer screening. Urology 1994; 43:480-487.
23. Davis SW, Nealson ED, and Stone JC. Evaluation of the National Cancer Institute's Clinical Trial Booklet. Journal of the National Cancer Institute Monographs 1993; 14:193-195.
24. Polednak AP and Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer 1993; 70:2152-2158.